PulseSight Therapeutics SAS, an ophthalmology clinical stage biotech company developing disruptive vectorized gene therapies with minimally-invasive delivery technology, is pleased to announce the ...

Companies across the globe are diligently working toward developing novel Dry Age Macular Degeneration treatment therapies ...

The evidence evaluating the effect of cataract surgery on the chances people with dry age-related macular degeneration (AMD) will convert to the more severe wet form of the condition has been uneven ...

The MarketWatch News Department was not involved in the creation of this content. Partnership includes manufacturing and launch in Australia and New Zealand, with additional markets to follow. WINDSOR ...

At least 20 million Americans ages 40 and older have age-related macular degeneration, and the threat posed by the vision-robbing condition will only grow larger as the population ages. Despite the ...

Annexon, Inc. reports complete enrollment in the ARCHER II trial for vonaprument, targeting dry AMD with topline data due 2026. Annexon, Inc. announced the successful completion of enrollment for its ...

Ahead of her 91st birthday on Tuesday, Dame Judi Dench has opened up about her worsening eyesight. The beloved actress was first diagnosed with age-related macular degeneration (AMD) in 2012, and ...

GENEVA--(BUSINESS WIRE)-- Alcon, the global leader in eye care dedicated to helping people see brilliantly, today announced its intention to acquire LumiThera, Inc., a leader in light-based ...

Instant coffee consumption has been linked to age-related macular degeneration (AMD), which can cause blindness. Researchers analyzed data of patients diagnosed with AMD for their study. The team ...

Annexon, Inc. has appointed Dr. Lloyd Clark as senior vice president of ophthalmology strategy and innovation, bringing over 25 years of experience in retina diseases and drug development. Dr. Clark, ...